Sarvodaya Cancer Hospital Delhi NCR proudly announces the first-time availability of Radium-223 therapy in India for patients with castration-resistant prostate cancer (CRPC) and predominant skeletal metastases. This milestone marks a new era in precision oncology, offering hope to patients with advanced…
Neuroendocrine Tumors: Symptoms, Causes, Risk Factors & Treatment
Neuroendocrine tumors (NETs) are a rare group of cancers that can grow in different parts of the body. They start in special cells called “neuroendocrine cells”, which help control how your body works by releasing hormones. These cells are found in…
Peptide Receptor Radionuclide Therapy PRRT Role in Neuroendocrine Cancer treatment
A Targeted Breakthrough in Treating Neuroendocrine Tumors By Using PRRT Being diagnosed with a neuroendocrine tumor (NET) can feel confusing and overwhelming. These rare tumors often grow slowly and may not cause symptoms for years. But when they do, they can…
Targeted Lu-177 (Lutetium) PSMA Therapy for Prostate Cancer: A New Hope for Men Fighting Advanced Disease
If you or a loved one is living with advanced prostate cancer, you may have heard about a new treatment called Lu-177 PSMA therapy. It’s one of the most promising breakthroughs in cancer care—and it’s changing lives by offering hope where…
Nuclear Medicine Therapy for Prostate Cancer: Options, Side Effects & Success Rates
If you or a loved one is facing advanced prostate cancer, you may have heard about new treatments using nuclear medicine or simply put, Theranostics. These therapies – Lutetium-177 (Lu-177), Actinium-225 (Ac-225), and Terbium-161 (Tb-161) – are offering new hope to…
Actinium-225 PSMA Therapy: A New Hope for Prostate Cancer Patients in India
If you or your loved one is living with advanced prostate cancer and have already tried several treatments like chemotherapy or Lutetium-177 therapy, there’s a new and promising option available: “Actinium-225 PSMA therapy”. What Is Actinium-225 Therapy? This treatment uses a…
PSMA Theranostics: A New Way to See and Treat Advanced Prostate Cancer
If you or a loved one is living with advanced prostate cancer that’s stopped responding to hormone therapy, there’s a new kind of hope on the horizon. It’s called “PSMA theranostics” — and while the name sounds technical, the idea is…
Terbium-161 Radionuclide Therapy in Cancer: A Promising Innovation in Nuclear Medicine
Cancer treatment has evolved significantly over the years, with targeted radionuclide therapy emerging as a revolutionary approach. Among the latest advancements in nuclear medicine is “Terbium-161 radionuclide therapy”, which holds tremendous potential for treating various types of cancer, particularly prostate cancer…